Medicare is scheduled to start negotiating lower prices in the fall with drug companies as a part of the Inflation Reduction Act President Biden signed in 2022, but several of the largest players hope they never have to negotiate at all. Leading industry groups sued the administration in June, claiming the program violates the First and Fifth Amendments. Josh Nathan-Kazis, health care reporter for Barron’s, joined CBS News to examine the legal arguments in the case.
View CBS News In
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
A lawsuit filed by a California woman who alleged that Subway’s tuna doesn’t contain any actual tuna has been dismissed, court records show. The case was dismissed “with prejudice,” which means it is a permanent dismissal and cannot be brought back to court. Plaintiff Nilima Amin in April had filed […]
